Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Acro Biomedical Co., Ltd. (6748:TWSE), powered by AI.
Acro Biomedical Co., Ltd. is currently trading at $134.50. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Acro Biomedical Co., Ltd. on Alpha Lenz.
View Acro Biomedical Co., Ltd.'s valuation metrics on Alpha Lenz.
“Acro Biomedical Co., Ltd.'s ROE is -9.6%. Explore profitability and growth together.”
Ask for details →Acro Biomedical Co., Ltd. is a healthcare company specializing in the development and manufacturing of medical-grade regenerative biomaterials. Founded in 2014 and based in Kaohsiung, Taiwan, the company focuses on creating advanced biomaterial medical devices for applications in human tissue engineering and regenerative medicine. Its products serve critical roles in a variety of fields, including wound care, orthopedics, dentistry, cardiovascular surgery, ophthalmology, and cosmetic micro plastic surgery. Leveraging collaborations with prominent scientific institutes and medical centers in Taiwan, Acro Biomedical integrates multidisciplinary research and innovation to address unmet medical needs, particularly in tissue repair and regeneration. The company has received multiple regulatory approvals and patents for its biomaterial technologies, targeting both domestic and international markets. By emphasizing high standards in biomaterial purification and device manufacturing, Acro Biomedical Co., Ltd. supports the ongoing advancement of medical treatments and specialty care across the healthcare sector.
“Acro Biomedical Co., Ltd.'s ROE is -9.6%. Explore profitability and growth together.”
Ask for details →Acro Biomedical Co., Ltd. (ticker: 6748) is a company listed on TWSE in the Healthcare sector (Biotechnology).
The current price is 134.5 with a P/E ratio of -x and P/B of -x.
ROE is -9.55% and operating margin is -242.80%. Annual revenue is $38M.